Legislation Strengthens Ban on Corporate Control of Medicine
Private Equity Influence in Health Care: The California Medical Association (CMA) is backing a new bill to reinforce California’s existing ban on the corporate practice of medicine. SB 351, introduced by State Sen. Christopher Cabaldon (D-West Sacramento), aims to restore trust in the state’s health care system by ensuring that physicians—not corporate investors—retain autonomy in patient care.
Protecting Physician Autonomy – Private Equity Influence in Health Care
SB 351 grants the California Attorney General’s office greater authority to investigate and intervene when private equity firms exert undue influence over medical decisions. The bill safeguards patients by ensuring that medical care is based on clinical judgment, not financial incentives.
CMA President Shannon Udovic-Constant, M.D., emphasized the urgency of this reform:
“The financial interests of private equity firms are often in direct conflict with the ethical and professional standards for quality medical care. This bill is critical to protecting the physician-patient relationship and ensuring that decisions about patient care are made by doctors—not by financial groups looking to maximize profits.”
Why It Matters
Private equity ownership in health care has surged in recent years, often prioritizing cost-cutting measures and profitability over patient outcomes and physician autonomy. SB 351 seeks to prevent these conflicts of interest and uphold the integrity of medical decision-making in California. Private Equity Influence in Health Care
Stay Informed
For more updates on health care policy, visit:
WCIRB Submits 2025 Regulatory Filing to California Insurance Commissioner
California Labor Commissioner’s Office Expands Efforts to Prevent Wage Theft
DWC Opens 15-Day Public Comment Period on Utilization Review Regulations
DWC Seeks Physicians and Pharmacists for Pharmacy & Therapeutics Committee 2025-2027 Term
For more health care news, visit MedLegalNews.com.
